How do you diagnose TCC in dogs?
Generally this includes a complete physical exam, CBC (complete blood cell count), blood chemistry, urinalysis, thoracic radiographs (chest X-rays), abdominal ultrasound, and a urine culture.
Diagnosis of TCC is typically made with either urine cytology or a tissue biopsy sample, often collected by cystoscopy..
How do you test for transitional cell carcinoma in dogs?
Generally this includes a complete physical exam, CBC (complete blood cell count), blood chemistry, urinalysis, thoracic radiographs (chest X-rays), abdominal ultrasound, and a urine culture.
Diagnosis of TCC is typically made with either urine cytology or a tissue biopsy sample, often collected by cystoscopy..
What are transitional cells in dogs?
Transitional cell carcinoma (TCC), also referred to as urothelial carcinoma, is the most common form of urinary bladder cancer in dogs, affecting tens of thousands of dogs worldwide each year.
Canine TCC is usually a high grade invasive cancer..
What causes TCC in dogs?
The exact cause of TCC in an individual dog is usually not known.
In general, canine TCC results from a combination of several factors including genetic predisposition and environmental factors.
A genetic predisposition is strongly suspected because TCC is more common in specific breeds of dogs..
What is transitional cell carcinoma bladder cytology dog?
A non-invasive test for TCC has been validated for dogs.
It turns out that 85 percent of canine transitional cell carcinomas have a specific mutation in a gene called BRAF.
This mutation can be detected in a urine sample, sometimes well before the tumor is visible via the special imaging described..
What is transitional cell carcinoma in dogs urine cytology?
A non-invasive test for TCC has been validated for dogs.
It turns out that 85 percent of canine transitional cell carcinomas have a specific mutation in a gene called BRAF.
This mutation can be detected in a urine sample, sometimes well before the tumor is visible via the special imaging described..
- Any damage that results in a separation (desquamation) of the surface cells of the renal pelvis, ureters, bladder or first segments of the urethra will lead to a high number of transitional cells in the urine specimen (urothelial polyp, tumour or cancer, usually of the bladder).
- Cystoscopy is the method of choice for evaluation of the primary tumor in patients with bladder carcinoma.
- Transitional cells are able to change shape and stretch.
They make up the lining of the renal pelvis, ureters, bladder and urethra.
The lining of these organs need cells that can stretch to expand when urine is stored in or flows through them.